Clinical trial SPARKLE-P
Metastasis-directed therapy for oligorecurrent prostate cancer: a randomized phase III trial
| Organ | prostate |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Oui |
| Sponsor | UZ-K.U.Leuven |
| EudraCT Identifier | 2022-502373-42-00 |
| Last update |